VFRM
Veritas Farms, Inc. [VFRM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
VFRM Stock Summary
In the News
VFRM Financial details
Company Rating
Neutral
Market Cap
2.79M
Income
-6.79M
Revenue
730.65K
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
17
Optionable
No
Shortable
Yes
Earnings
17 Apr 2024
P/E
-0.29
Forward P/E
-
PEG
0.23
P/S
4.93
P/B
9.49
P/C
-
P/FCF
-2.19
Quick Ratio
0.03
Current Ratio
0.65
Debt / Equity
19
LT Debt / Equity
17.57
-
-
EPS (TTM)
-0.15
EPS next Y
-
EPS next Q
-
EPS this Y
-41.18%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-12.05%
Revenue last 5Y
-12.56%
Revenue Q/Q
38.9%
EPS Q/Q
-62.76%
-
-
-
-
SMA20
-
SMA50
-33.33%
SMA100
-50%
Inst Own
0%
Inst Trans
-0.02%
ROA
-82%
ROE
802%
ROC
-1.27%
Gross Margin
-220%
Oper. Margin
-671%
Profit Margin
-929%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.014-0.072
52W High
-
52W Low
-
RSI
50.58
Rel Volume
0.03
Avg Volume
5.74K
Volume
175
Perf Week
1.01%
Perf Month
-17.75%
Perf Quarter
-
Perf Half Y
-34.53%
-
-
-
-
Beta
1.127
-
-
Volatility
0%, 0%
Prev Close
15.75%
Price
0.02095
Change
8.16%
VFRM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.11 | 0.21 | 0.15 | 0.07 | 0.03 | |
| Net income per share | -0.19 | -0.32 | -0.18 | -0.17 | -0.1 | |
| Operating cash flow per share | -0.21 | -0.35 | -0.07 | -0.11 | -0.09 | |
| Free cash flow per share | -0.24 | -0.39 | -0.07 | -0.11 | -0.09 | |
| Cash per share | 0.01 | 0.03 | 0 | 0.01 | 0 | |
| Book value per share | 0.31 | 0.35 | 0.18 | 0.11 | -0.01 | |
| Tangible book value per share | 0.31 | 0.35 | 0.18 | 0.11 | -0.02 | |
| Share holders equity per share | 0.31 | 0.35 | 0.18 | 0.11 | -0.01 | |
| Interest debt per share | 0.03 | 0.01 | 0.06 | 0.05 | 0.12 | |
| Market cap | 23.69M | 32.98M | 7.33M | 2.13M | 478.69K | |
| Enterprise value | 24.04M | 32.29M | 9.52M | 3.62M | 5.01M | |
| P/E ratio | -6.18 | -2.95 | -0.95 | -0.29 | -0.11 | |
| Price to sales ratio | 11.39 | 4.52 | 1.18 | 0.69 | 0.45 | |
| POCF ratio | -5.69 | -2.69 | -2.47 | -0.45 | -0.12 | |
| PFCF ratio | -4.97 | -2.41 | -2.4 | -0.44 | -0.12 | |
| P/B Ratio | 3.9 | 2.7 | 0.96 | 0.44 | -0.79 | |
| PTB ratio | 3.9 | 2.7 | 0.96 | 0.44 | -0.79 | |
| EV to sales | 11.56 | 4.43 | 1.53 | 1.17 | 4.71 | |
| Enterprise value over EBITDA | -5.82 | -3.03 | -1.42 | -0.53 | -1 | |
| EV to operating cash flow | -5.77 | -2.63 | -3.21 | -0.76 | -1.29 | |
| EV to free cash flow | -5.05 | -2.35 | -3.11 | -0.75 | -1.28 | |
| Earnings yield | -0.16 | -0.34 | -1.05 | -3.4 | -9.06 | |
| Free cash flow yield | -0.2 | -0.42 | -0.42 | -2.28 | -8.15 | |
| Debt to equity | 0.08 | 0.03 | 0.3 | 0.41 | -7.57 | |
| Debt to assets | 0.07 | 0.03 | 0.18 | 0.23 | 0.68 | |
| Net debt to EBITDA | -0.08 | 0.06 | -0.33 | -0.22 | -0.91 | |
| Current ratio | 4.11 | 4.94 | 1.77 | 1.83 | 1.12 | |
| Interest coverage | -154.79 | -612.62 | -57.6 | -48.11 | -11.25 | |
| Income quality | 1.09 | 1.1 | 0.39 | 0.65 | 0.76 | |
| Dividend Yield | 0 | 0 | 0 | 0.09 | 0 | |
| Payout ratio | 0 | 0 | 0 | -0.03 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0.01 | 0.01 | |
| Capex to operating cash flow | 0.14 | 0.12 | 0.03 | 0.02 | 0 | |
| Capex to revenue | -0.29 | -0.2 | -0.01 | -0.03 | -0.01 | |
| Capex to depreciation | -2.18 | -2.97 | -0.12 | -0.16 | -0.02 | |
| Stock based compensation to revenue | 0.61 | 0.33 | 0.33 | 0.07 | 0.11 | |
| Graham number | 1.16 | 1.59 | 0.86 | 0.65 | 0.18 | |
| ROIC | -0.56 | -0.88 | -0.7 | -1.04 | -1.09 | |
| Return on tangible assets | -0.55 | -0.79 | -0.63 | -0.85 | -0.64 | |
| Graham Net | 0.03 | 0.08 | -0.03 | -0.04 | -0.14 | |
| Working capital | 2.3M | 7.04M | 2.9M | 1.83M | 364.84K | |
| Tangible asset value | 6.08M | 12.14M | 7.59M | 4.77M | -661.28K | |
| Net current asset value | 2.1M | 6.8M | 1.9M | 269.14K | -3.87M | |
| Invested capital | 0.08 | 0.03 | 0.3 | 0.41 | -7.57 | |
| Average receivables | 162.03K | 383.59K | 454.71K | 245.58K | 381.56K | |
| Average payables | 217.26K | 878.52K | 1.79M | 1.72M | 1.34M | |
| Average inventory | 1.97M | 4.55M | 6.25M | 4.55M | 2.73M | |
| Days sales outstanding | 42.84 | 26.18 | 22.65 | 12.41 | 226.03 | |
| Days payables outstanding | 57.44 | 149.35 | 225.66 | 126.46 | 186.17 | |
| Days of inventory on hand | 760.82 | 628.83 | 658.02 | 285.37 | 334.6 | |
| Receivables turnover | 8.52 | 13.94 | 16.11 | 29.41 | 1.61 | |
| Payables turnover | 6.35 | 2.44 | 1.62 | 2.89 | 1.96 | |
| Inventory turnover | 0.48 | 0.58 | 0.55 | 1.28 | 1.09 | |
| ROE | -0.63 | -0.92 | -1.01 | -1.5 | 7.15 | |
| Capex per share | -0.03 | -0.04 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0.01 | 0 | 0 | |
| Net income per share | -0.02 | -0.07 | -0.03 | -0.03 | -0.01 | |
| Operating cash flow per share | -0.02 | -0.01 | 0 | -0.01 | -0.01 | |
| Free cash flow per share | -0.02 | -0.01 | 0 | -0.01 | -0.01 | |
| Cash per share | 0 | 0 | 0.01 | 0 | 0 | |
| Book value per share | 0.04 | -0.01 | -0.04 | -0.03 | 0 | |
| Tangible book value per share | 0.04 | -0.02 | -0.04 | -0.03 | -0.03 | |
| Share holders equity per share | 0.04 | -0.01 | -0.04 | -0.03 | 0 | |
| Interest debt per share | 0.1 | 0.11 | 0.12 | 0.09 | 0.05 | |
| Market cap | 666.01K | 478.69K | 3.02M | 1.96M | 3.91M | |
| Enterprise value | 4.63M | 5.01M | 7.49M | 5.21M | 7.79M | |
| P/E ratio | -0.17 | -0.04 | -0.61 | -0.34 | -0.86 | |
| Price to sales ratio | 3.69 | 4.16 | 14.39 | 11.52 | 16.55 | |
| POCF ratio | -0.65 | -0.8 | 49.73 | -3.86 | -6.52 | |
| PFCF ratio | -0.65 | -0.8 | 49.73 | -3.86 | -6.52 | |
| P/B Ratio | 0.38 | -0.79 | -1.86 | -1.43 | 18.82 | |
| PTB ratio | 0.38 | -0.79 | -1.86 | -1.43 | 18.82 | |
| EV to sales | 25.67 | 43.54 | 35.7 | 30.7 | 33.01 | |
| Enterprise value over EBITDA | -6.52 | -2.49 | -10.71 | -4.6 | -9.84 | |
| EV to operating cash flow | -4.5 | -8.42 | 123.42 | -10.3 | -13 | |
| EV to free cash flow | -4.5 | -8.35 | 123.42 | -10.3 | -13 | |
| Earnings yield | -1.5 | -6.25 | -0.41 | -0.73 | -0.29 | |
| Free cash flow yield | -1.54 | -1.25 | 0.02 | -0.26 | -0.15 | |
| Debt to equity | 2.32 | -7.57 | -2.98 | -2.47 | 19 | |
| Debt to assets | 0.49 | 0.68 | 0.76 | 0.62 | 0.47 | |
| Net debt to EBITDA | -5.58 | -2.25 | -6.39 | -2.87 | -4.9 | |
| Current ratio | 1.58 | 1.12 | 0.91 | 0.64 | 0.65 | |
| Interest coverage | -6.12 | -13.81 | -4.6 | -5.64 | -2.37 | |
| Income quality | 0.95 | 0.3 | -0.07 | 0.36 | 0.53 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.31 | |
| Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0 | |
| Capex to revenue | 0 | -0.05 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | -0.05 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0.08 | 0.07 | 0.02 | 0.15 | 0.15 | |
| Graham number | 0.15 | 0.15 | 0.16 | 0.16 | 0.03 | |
| ROIC | -0.14 | -0.66 | -0.29 | -0.62 | -0.22 | |
| Return on tangible assets | -0.12 | -0.44 | -0.2 | -0.26 | -0.2 | |
| Graham Net | -0.1 | -0.14 | -0.16 | -0.14 | -0.08 | |
| Working capital | 1.66M | 364.84K | -296.07K | -1.37M | -1.55M | |
| Tangible asset value | 1.71M | -661.28K | -1.68M | -1.42M | -2.4M | |
| Net current asset value | -2.06M | -3.87M | -4.79M | -4.42M | -5.2M | |
| Invested capital | 2.32 | -7.57 | -2.98 | -2.47 | 19 | |
| Average receivables | 560.29K | 720.77K | 365.86K | 66.47K | 61.96K | |
| Average payables | 1.31M | 1.26M | 1.25M | 1.24M | 1.44M | |
| Average inventory | 3.48M | 2.88M | 2.2M | 1.92M | 1.99M | |
| Days sales outstanding | 390.71 | 514.97 | 31.48 | 31.56 | 24.55 | |
| Days payables outstanding | 312.74 | 78.06 | 698.21 | 198.67 | 811.4 | |
| Days of inventory on hand | 867.77 | 140.29 | 1.21K | 272.24 | 1.13K | |
| Receivables turnover | 0.23 | 0.17 | 2.86 | 2.85 | 3.67 | |
| Payables turnover | 0.29 | 1.15 | 0.13 | 0.45 | 0.11 | |
| Inventory turnover | 0.1 | 0.64 | 0.07 | 0.33 | 0.08 | |
| ROE | -0.57 | 4.93 | 0.77 | 1.04 | -5.47 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
VFRM Frequently Asked Questions
What is Veritas Farms, Inc. stock symbol ?
Veritas Farms, Inc. is a US stock , located in Dania beach of Fl and trading under the symbol VFRM
What is Veritas Farms, Inc. stock quote today ?
Veritas Farms, Inc. stock price is $0.02095 today.
Is Veritas Farms, Inc. stock public?
Yes, Veritas Farms, Inc. is a publicly traded company.
Company Profile
- Volume Average 5.74K
- Market Capitalization 2.79M
- Employee 17
- CEO Mr. Thomas E. Vickers
- Headquarters Dania Beach,FL,US
- IPO Date 2017-09-06
-
Website
https://www.theveritasfarms.com 
Veritas Farms, Inc. focuses on producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include capsules, gummies, tinctures, lotions, salves, vape oils, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Dania Beach, Florida.
